Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benlysta on pneumococcal vaccine response in SLE
NCT01597492Phase 4Completed
- Sponsor
- GSK
- Start
- May 2012
- Primary completion
- Sep 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of belimumab in systemic lupus erythematosus (SLE) (2 arms), sponsored by GSK. Primary endpoint: Number of Participants With Positive Antibody Responses to at Least One of the 23 Pneumococcal Vaccine Serotypes. Started May 2012; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01597492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01597492.